The Centers for Medicare and Medicaid Services (CMS) has finalized its proposal to significantly lower Medicare Part B payments to hospital outpatient departments for drugs purchased at 340B rates, which could be a sign the Administration will pursue other reforms in the drug discount program.
The change doesn't impact requirements that manufacturers provide 340B discounts. Nevertheless, the rule "shines a spotlight on what's going on...






